Yutaka Seino. Show Affiliations »
Abstract
Mesh: See more » Adamantane/analogs & derivativesAdamantane/pharmacologyAnimalsBlood Glucose/drug effectsBlood Glucose/metabolismComprehensionDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/metabolismDipeptidyl Peptidase 4/metabolismDipeptidyl-Peptidase IV Inhibitors/pharmacologyGastric Inhibitory Polypeptide/bloodGlucagon-Like Peptide 1/bloodHumansIncretins/pharmacologyIncretins/physiologyNitriles/pharmacologyPyrrolidines/pharmacologyRandomized Controlled Trials as TopicVildagliptin
Substances: See more » Blood GlucoseDipeptidyl-Peptidase IV InhibitorsIncretinsNitrilesPyrrolidinesGastric Inhibitory PolypeptideGlucagon-Like Peptide 1DPP4 protein, humanDipeptidyl Peptidase 4VildagliptinAdamantane
Year: 2011 PMID: 21474688 DOI: 10.1210/jc.2011-0329
Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN: 0021-972X Impact factor: 5.958